Skip to main content
Logo GMV

Main navigation

  • Sectors
    • Icono espacio
      Space
    • Icono Aeronáutica
      Aeronautics
    • Icono Defensa y Seguridad
      Defense and Security
    • Icono Sistemas Inteligentes de Transporte
      Intelligent Transportation Systems
    • Icono Automoción
      Automotive
    • Icono Ciberseguridad
      Cybersecurity
    • Icono Servicios públicos Digitales
      Digital Public Services
    • Icono Sanidad
      Healthcare
    • Icono Industria
      Industry
    • Icono Financiero
      Financial
    • Icono Industria
      Services
    • All Sectors

    Highlight

    EMV Transit
    EMV Transit: technology that keeps on working
  • Talent
  • About GMV
    • Get to Know the Company
    • History
    • Management Team
    • Certifications
    • Corporate Social Responsibility
  • Communication
    • News
    • Events
    • Blog
    • Magazine GMV News
    • Press Room
    • Media library
    • Latest from GMV

Secondary navigation

  • Products A-Z
  • GMV Global
    • Global (en)
    • Spain and LATAM (es - ca - en)
    • Germany (de - en)
    • Portugal (pt - en)
    • Poland (pl - en)
    • All branches and all GMV sites
  • Home
  • Communication
  • News
Back
New search
Date
  • Healthcare

La Luz, Spain´s first private hospital to take up the worlds´s first simulator capable of forecasting the effect of intraoperative radiotherapy

28/05/2012
  • Print
Share

Clínica La Luz, Spain´s first private hospital to take up the worlds´s first simulator capable of forecasting the effect of intraoperative radiotherapy
Clínica La Luz in Madrid has become Spain’s first private hospital to take up the new intraoperative radiation therapy planner radiance™. This virtual simulator is a world first, forecasting the effect of radiation therapy on tissues, planning the irradiation zone in a precise way and thus avoiding any damage to surrounding healthy tissue.

Specialists in intraoperative radiotherapy of tumors can now work from a more complete patient analysis for decision-taking before the surgery goes ahead, helping to identify the best possible treatment for each particular case.

radiance™ has been developed by the Spanish group GMV in collaboration with a research team led by the Hospital Universitario Gregorio Marañón and a set of prestigious Spanish hospitals and universities.

Since 2001, when radiation oncology started in La Luz, the clinic has been providing an intraoperative radiation therapy service in its unit; this in itself bears out its experience in this technique. This planner now makes La Luz a worldwide trailblazer among all the other hospitals offering this subspecialism and also the first private clinic in Spain to buy this simulator.

Radiation therapy is a type of oncology treatment that uses ionizing radiation to destroy, inactivate and control the tumor cells. Radiation therapy, together with surgery and chemotherapy, is one of the three pillars of cancer treatment today. It is estimated that over 50% of cancer patients will need radiation therapy for tumor control or as palliative therapy at some moment during the disease.

Intraoperative radiation therapy is a technique for directing a single high-intensity radiation dose at the tumor bed during surgery, immediately after extirpation of the tumor, or at any residual disease, protecting the surrounding radiation-sensitive healthy tissue and organs. This technique reduces the recurrence risk of many types of tumor such as rectum cancer, sarcomas, breast cancer, etc, and improves the curative chances of locally recurrent cancer. It has an important palliative effect in other types of hard-to-treat cancers such as pancreas cancer.

Intraoperative radiation therapy also cuts down treatment time and the number of hospital visits in certain cases such as early breast cancer, in which it can partially or even totally replace external radiotherapy, reducing the overall treatment time by up to 6 weeks. It might even become the exclusive oncology treatment in certain cases. This type of radiotherapy can also minimize the secondary effects on healthy tissue (chronic sequels) and therefore optimizes the use of healthcare resources.

  • Print
Share

Related

Premios IA con Impacto Social
  • Healthcare
The GMV-led Tartaglia project wins the "AI with Social Impact Prize".
np_011_ia-lung-scan.jpg
  • Healthcare
Innovative artificial intelligence-based simulator for the diagnosis of interstitial lung diseases
np_011_ia-lung-scan.jpg
  • Healthcare
GMV designs a groundbreaking artificial intelligence-based simulator for diagnosing interstitial lung diseases

Contact

Ul. Hrubieszowska 2
Varsovia, 01-209 Poland

Tel. +48 223955165
Fax. +48 223955167

Contact menu

  • Contact
  • GMV around the world

Blog

  • Blog

Branże

Sectors menu

  • Space
  • Aeronautics
  • Defense and Security
  • Intelligent Transportation Systems
  • Automotive
  • Cybersecurity
  • Digital Public Services
  • Healthcare
  • Industry
  • Financial
  • Services
  • Talent
  • About GMV
  • Shortcut to
    • Press Room
    • News
    • Events
    • Blog
    • Products A-Z
© 2025, GMV Innovating Solutions S.L.

Footer menu

  • Contact
  • Legal Notice
  • Privacy Policy
  • Cookie Policy

Footer Info

  • Commitment to the Environment
  • Financial Information